We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-6.51%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$202M
AUM Growth
+$14.7M
(+7.8%)
Cap. Flow
+$37.7M
Cap. Flow
% of AUM
18.62%
Top 10 Holdings %
Top 10 Hldgs %
75.02%
Holding
61
New
16
Increased
10
Reduced
11
Closed
13
Top Buys
| 1 |
Centene
CNC
|
+$30.7M |
| 2 |
GE HealthCare
GEHC
|
+$14.1M |
| 3 |
Cigna
CI
|
+$10.1M |
| 4 |
ADC Therapeutics
ADCT
|
+$7.97M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
+$7.12M |
Top Sells
| 1 |
MSAC
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
|
+$23.4M |
| 2 |
STAAR Surgical
STAA
|
+$7.63M |
| 3 |
Icon
ICLR
|
+$6.6M |
| 4 |
HSKA
Heska Corp
HSKA
|
+$5.61M |
| 5 |
Protagonist Therapeutics
PTGX
|
+$4.74M |
Sector Composition
| 1 | Healthcare | 98.68% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Centene
CNC
$33.9B
| $27.4M | 13.53% |
+432,834
| New | +$30.7M |
|
|
2
Cigna
CI
$80.2B
| $22.3M | 11.01% |
87,175
+34,564
| +66% | +$10.1M |
|
|
BCYC
3
Bicycle Therapeutics
BCYC
$294M
| $20.6M | 10.17% |
967,347
+283,922
| +42% | +$7.12M |
|
4
Cencora
COR
$58.8B
| $20.5M | 10.14% |
128,164
+43,765
| +52% | +$6.94M |
|
5
United Therapeutics
UTHR
$22.4B
| $16.8M | 8.3% |
75,003
+20,044
| +36% | +$4.94M |
|
|
6
GE HealthCare
GEHC
$28B
| $16.2M | 7.98% |
+196,887
| New | +$14.1M |
|
7
Organon & Co
OGN
$3.55B
| $11.1M | 5.48% |
471,553
-116,283
| -20% | -$3.12M |
|
8
Medtronic
MDT
$102B
| $6.77M | 3.35% |
84,012
-43,988
| -34% | -$3.59M |
|
9
Avantor
AVTR
$7.71B
| $5.99M | 2.96% |
283,136
+33,136
| +13% | +$755K |
|
|
10
ADC Therapeutics
ADCT
$156M
| $4.21M | 2.08% |
+2,160,632
| New | +$7.97M |
|
11
Viking Therapeutics
VKTX
$4.41B
| $4.16M | 2.06% |
+250,000
| New | +$2.58M |
|
|
AXNX
12
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.87M | 1.91% |
+70,841
| New | +$4.14M |
|
13
Globus Medical
GMED
$10.3B
| $3.82M | 1.89% |
+67,500
| New | +$4.33M |
|
14
Relay Therapeutics
RLAY
$4.16B
| $3.79M | 1.87% |
+230,013
| New | +$4.12M |
|
|
MACK
15
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3.35M | 1.66% |
272,843
+22,843
| +9% | +$268K |
|
16
Revolution Medicines
RVMD
$39.3B
| $2.73M | 1.35% |
+125,957
| New | +$3.1M |
|
|
EUCRU
17
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $2.58M | 1.27% |
248,674
| – | – |
|
|
RPTX
18
DELISTED
Repare Therapeutics
RPTX
| $2.25M | 1.11% |
+228,538
| New | +$2.62M |
|
|
CTIC
19
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.21M | 1.09% |
526,239
+196,239
| +59% | +$1.02M |
|
20
Savara
SVRA
$1.17B
| $1.85M | 0.91% |
948,457
+82,009
| +9% | +$185K |
|
21
Pharvaris
PHVS
$2.41B
| $1.84M | 0.91% |
228,385
-56,615
| -20% | -$498K |
|
|
HSKA
22
DELISTED
Heska Corp
HSKA
| $1.7M | 0.84% |
17,450
-66,859
| -79% | -$5.61M |
|
|
ELEV
23
DELISTED
Elevation Oncology
ELEV
| $1.67M | 0.82% |
876,611
+516,880
| +144% | +$667K |
|
24
Inogen
INGN
$171M
| $1.52M | 0.75% |
121,535
-165,157
| -58% | -$3.16M |
|
|
NYXH
25
Nyxoah
NYXH
$158M
| $1.41M | 0.7% |
188,875
+172,765
| +1,072% | +$969K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA